Association of PON1, P2Y12 and COX1 with Recurrent Ischemic Events in Patients with Extracranial or Intracranial Stenting

• DOI: 10.1371/journal.pone.0148891
• Publication Date: 2016-02-12T19:02:07Z
• Authors: Xiao-Qing Li; Ning Ma; Xin-Gang Li; Bo Wang; Shu-Sen Sun; Feng Gao; Da-Peng Mo; Li-Gang Song; Xuan Sun; Lian Liu; Xing-Quan Zhao; Yi-Long Wang; Yong-Jun Wang; Zhi-Gang Zhao; Zhong-Rong Miao
• Keywords: Male; Science; Polymorphism, Single Nucleotide; Linkage Disequilibrium; Brain Ischemia; 03 medical and health sciences; 0302 clinical medicine; Gene Frequency; Recurrence; Humans; Genetic Predisposition to Disease; Genetic Association Studies; Aged; Aryldialkylphosphatase; Q; R; Middle Aged; Receptors, Purinergic P2Y12; 3. Good health; Case-Control Studies; Cyclooxygenase 1; Medicine; Female; Stents; Research Article

Short-term combined use of clopidogrel and aspirin improves cerebrovascular outcomes in patients with symptomatic extracranial or intracranial stenosis. Antiplatelet non-responsiveness is related to recurrent ischemic events, but the culprit genetic variants responsible for the non-responsiveness have not been well studied. We aimed to identify the genetic variants associated with poor clinical outcomes.Patients with symptomatic extracranial or intracranial stenosis scheduled for stenting and receiving dual antiplatelets (clopidogrel 75 mg and aspirin 100 mg daily) for at least 5 days before intervention were enrolled. Ischemic events including recurrent transient ischemic attack, stroke, myocardial infarction, and vascular-related mortality within 12 months follow-up were recorded. We examined the influence of genetic polymorphisms on treatment outcome in our patients.A total of 268 patients were enrolled into our study and ischemic events were observed in 39 patients. For rs662 of paraoxonase 1 (PON1), allele C was associated with an increased risk of ischemic events (OR = 1.64, 95%CI = 1.03-2.62, P = 0.029). The A-allele carriers of rs2046934 of P2Y12 had a significant association with adverse events (OR = 2.01, 95%CI = 1.10-3.67, P = 0.041). The variant T-allele of cyclooxygenase-1 (COX1) rs1330344 significantly increased the risk of recurrent clinical events (OR = 1.85, 95%CI = 1.12-3.03, P = 0.017). The other single nucleotide polymorphism (SNP) had no association with ischemic events.PON1, P2Y12 and COX1 polymorphisms were associated with poorer vascular outcomes. Testing for these polymorphisms may be valuable in the identification of patients at risk for recurrent ischemic events.